Simmons First Trust’s GSK GSK Stock Holding History

Simmons First Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$1.61M	Buy	+31,856	New	+$1.62M	0.18%	109

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Simmons First Trust's GSK Position: Q4 2015 in Review

Simmons First Trust opened a new position in GSK (GSK) in Q4 2015: 31,856 shares worth $1.61M. The stake represents 0.18% of the portfolio and ranks #109 among its holdings.

718 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

Simmons First Trust held 31,856 shares of GSK worth $1.61M as of Q4 2015.
GSK was a new Simmons First Trust position in Q4 2015.
GSK made up 0.18% of Simmons First Trust's portfolio in Q4 2015, its #109 holding.
718 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on Simmons First Trust's 13F filing for Q4 2015, filed 1 Feb 2016.